APA (7th ed.) Citation
(2026). Soluble ST2 as a biomarker for predicting severe adverse events among pediatric patients with Mycoplasma pneumoniae pneumonia. PLOS ONE.
Chicago Style (17th ed.) Citation
"Soluble ST2 as a Biomarker for Predicting Severe Adverse Events Among Pediatric Patients with Mycoplasma Pneumoniae Pneumonia." PLOS ONE 2026.
MLA (9th ed.) Citation
"Soluble ST2 as a Biomarker for Predicting Severe Adverse Events Among Pediatric Patients with Mycoplasma Pneumoniae Pneumonia." PLOS ONE, 2026.
Warning: These citations may not always be 100% accurate.